Condition: Hospital Acquired Pneumonia · Sponsor: Nantes University Hospital
Determine the efficacy of dexamethasone plus standard of care (SOC) as compared to placebo plus SOC for treating severe hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype; It's an international phase III, double-blind, placebo-controlled, randomized trial.
This description comes directly from the study's public registry record.
Antoine ROQUILLY · +33253482876 · antoine.roquilly@chu-nantes.fr
Lucile MARGUET · +33253482876 · lucile.marguet@chu-nantes.fr
Always discuss trial participation with your own doctor first.
| Chu Amiens | Amiens, France | Recruiting |
| CHU Angers | Angers, France | Recruiting |
| Chu Bordeaux | Bordeaux, France | Recruiting |
| Chu Bordeaux | Bordeaux, France | Not Yet Recruiting |
| CHU Brest | Brest, France | Recruiting |
| CHU Caen | Caen, France | Recruiting |
| CHU Clermont - Ferrand | Clermont-Ferrand, France | Recruiting |
| CHU Clermont-Ferrand | Clermont-Ferrand, France | Recruiting |
| CHU Clermont-Ferrand | Clermont-Ferrand, France | Recruiting |
| CHU Beaujon | Clichy, France | Recruiting |
| CHU Raymond Poincaré | Garches, France | Recruiting |
| Chu Grenoble | Grenoble, France | Recruiting |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06269900